| Apria Healthcare Inc | |
| 818 Main St, Ste H And I, Salmon, Idaho 83467 | |
| (208) 756-4794 |
| Name | Apria Healthcare Inc |
|---|---|
| Organization Name | Apria Healthcare Llc |
| Location | 818 Main St, Ste H And I, Salmon, Idaho 83467 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (208) 756-4794 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Exact Sciences Corp. today announced its financial results for the quarter ended Sept. 30, 2012.
Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, has announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance for a patent covering various aspects of a potent small interfering RNA (siRNA) sequence.
Pregnant women and the extremely obese are among those at high risk for complications from the flu - including death - and should be tested and begin antiviral treatment promptly if they are sick enough to be hospitalized with flu symptoms, according to updated guidelines released by the Infectious Diseases Society of America.
NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.
› Verified 1 days ago
| NPI Number | 1700995883 |
| Organization Name | APRIA HEALTHCARE LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 818 Main St, Suite H & I, Salmon, ID 83467 |
| Phone Number | 208-756-4794 |
News Archive
Exact Sciences Corp. today announced its financial results for the quarter ended Sept. 30, 2012.
Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, has announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance for a patent covering various aspects of a potent small interfering RNA (siRNA) sequence.
Pregnant women and the extremely obese are among those at high risk for complications from the flu - including death - and should be tested and begin antiviral treatment promptly if they are sick enough to be hospitalized with flu symptoms, according to updated guidelines released by the Infectious Diseases Society of America.
NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.
› Verified 1 days ago
News Archive
Exact Sciences Corp. today announced its financial results for the quarter ended Sept. 30, 2012.
Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, has announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance for a patent covering various aspects of a potent small interfering RNA (siRNA) sequence.
Pregnant women and the extremely obese are among those at high risk for complications from the flu - including death - and should be tested and begin antiviral treatment promptly if they are sick enough to be hospitalized with flu symptoms, according to updated guidelines released by the Infectious Diseases Society of America.
NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.
› Verified 1 days ago
Apria Healthcare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 818 Main St, Salmon, Idaho 83467 Phone: (208) 756-4794 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1102 Main Street, Salmon, Idaho 83467 Phone: (208) 756-8708 | |
Saveway Market Pharmacy Type: Community/Retail Pharmacy Location: 1200 Shoup St, Salmon, Idaho 83467 Phone: (208) 756-1940 | |
Salmon River Vision Clinic Pllc Type: Medicare Supplier Location: 1301 Main Street, Salmon, Idaho 83467 Phone: (208) 756-2020 |